###### What is already known on this topic?

-   Environmental tobacco smoke exposure has a significant impact on paediatric health, including frequency of respiratory illness, bacterial meningitis and ear infections.

-   Smoking by adults increases their risk of anaesthetic and surgical complications, including delayed wound healing, increased respiratory complications and delayed discharge.

-   Appropriate preoperative smoking cessation in adults reduces the risk of these complications.

###### What this study adds?

-   This first review of the evidence identifies and summarises the effect of environmental tobacco smoke exposure on paediatric anaesthetic and surgical outcomes.

-   A pooled estimate suggests that environmental tobacco smoke exposure significantly increases risk of paediatric respiratory adverse events during the perianaesthetic period.

-   There is a need to establish whether household health promotion interventions and preoperative smoking cessation reduce the risk of harmful outcomes for children undergoing surgery.

Introduction {#s1}
============

Environmental tobacco smoke (ETS) exposure, also referred to as 'secondhand smoke' or 'passive smoking', is exposure to smoke from the burning of a tobacco product and smoke that is exhaled by smokers. ETS exposure has been demonstrated to have a significant impact on the health of children and young people. This includes increased incidence of respiratory infection,[@R1] asthma,[@R2] ear infection[@R3] and meningitis.[@R4] Children are more vulnerable than adults to ETS,[@R5] and there is consensus on the importance of protecting children from the harms of ETS exposure.[@R6]

Rationale {#s1a}
---------

In adults, there is evidence that tobacco smoking has a negative impact on surgical outcomes, including anaesthetic complications,[@R7] reduced wound and bone healing[@R8] [@R9] and increased morbidity and delayed discharge from hospital.[@R10] Appropriate cessation of smoking before an operative episode reduces the likelihood of these events and improves patient outcomes.[@R11] Economic benefits of effective preoperative smoking cessation have been modelled in adults, where cessation was conservatively estimated to save between one-half and three-quarters of a million pounds in London alone, with a potential to extend this to 5--13 million pounds with a more engaged programme.[@R12]

There is no similar evidence base around the impact of ETS exposure levels on surgery in children, and a review of PROSPERO abstracts suggests no similar systematic reviews (SRs) are in preparation.

Objectives {#s1b}
----------

The objective of this SR was to answer the structured question 'What is the evidence from observational studies that environmental tobacco smoke (ETS) exposure in children aged under 18 affects anaesthetic and surgical outcomes compared with those with lower or no ETS exposure?'

Methods {#s2}
=======

This SR was conducted in line with current PRISMA guidance. Review coauthors agreed the review protocol, which was submitted to the University of York PROSPERO International Prospective Register of Systematic Reviews (ID 42014014557).

Eligibility criteria {#s2a}
--------------------

Studies were eligible if they met the following four criteria:

\(A\) An observational study (as defined by the Cochrane Collaboration), including case--control, cohort, case--cohort, nested case--control and cross-sectional studies. Case studies, letters, editorials and reviews were excluded. Where relevant cohorts could be identified as nested within an interventional study (eg, a randomised controlled trial collecting ETS exposure as confounding), it was included.

\(B\) A population of children aged 18 or under undergoing any operative procedures, including studies of children, or containing a subgroup of children aged 18 or under.

\(C\) Study or subgroup analysis contained within it uses reported or observed ETS (eg, by parental questionnaire), or biological markers thereof, as an independent variable on outcome.

\(D\) Study included either any anaesthetic, recovery and surgical outcomes, for our protocol\'s primary outcomes, or secondary outcomes including length of stay, cost of care, patient experience or change in close contact smoking behaviours or ETS exposure. Any length of follow-up was accepted.

Information sources {#s2b}
-------------------

A standardised search protocol was developed and performed across all databases on 30 October 2014. We searched only English language publications.

MEDLINE (1946--2014), Embase (1974--2014) and PsycINFO (1967--2014) were searched via OVID, as well as IBSS (1951--2014) via ProQuest, CPCI (1990--2013) via Web of Science, CINAHL Plus (1964--2014) via EBSCO Health and OpenGray (inception--2014). The sample search strategy for MEDLINE is available in the online [supplementary file](#SM1){ref-type="supplementary-material"} S1. Reference lists of studies selected for inclusion were reviewed, but no further papers were identified. No contacts were made with authors to identify or obtain papers. Search results were imported into Mendeley (v1.12.3) and de-duplicated algorithmically, followed by manual inspection. A check was performed on final papers to confirm no duplicated publications.
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Study selection {#s2c}
---------------

Two reviewers (CC and YA) independently screened titles and abstracts against the eligibility criteria. Where there was no consensus, the reviewers engaged in dialogue, with unresolved papers taken forward to full review. Full papers were obtained for all abstracts taken forward, and reviewed independently by the two reviewers against a pre-established checklist. Again, consensus on inclusion was reached through dialogue. A third reviewer was available for resolution of disagreements, but was not required.

Data extraction {#s2d}
---------------

A data extraction template was created to capture participant numbers, specialty, inclusion and exclusion criteria, measurement of ETS exposure, whether ETS was a primary or secondary measure and how ETS exposure was categorised. Outcomes were captured, including type of outcome, length of study, statistical method, results and adjustments for bias and confounding. Where only rates or percentages were reported, these were used to calculate raw numbers for inclusion.

Wherever possible, total and included study participants, raw event numbers and summary statistics were extracted. Other specific outcomes, such as 'time to event' were captured narratively. Primary outcomes were classified into three categories: anaesthetic (eg, laryngospasm), immediate postsurgical (eg, bleeding) and long-term surgical (eg, disease resolution or improvement).

The extraction tool was piloted on a scoping study, and then applied consistently to all papers by a study reviewer (YA). Results were independently cross-checked by the second reviewer (CC).

Quality scoring {#s2e}
---------------

Studies that met the inclusion criteria were independently scored for methodological quality by the two reviewers using a modified eight-point version of the Newcastle--Ottawa quality assessment scale (<http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp>) recognised by the Cochrane Collaboration Non-Randomised Studies Working Group. The content validity and inter-rater reliability of the tool are already established. The study reviewers selected a score of 7 or more as an indicator of high methodological quality.

Statistical methods {#s2f}
-------------------

The protocol described that quantitative data synthesis would be undertaken where there were sufficient data. Surgical outcomes were too diverse, and are reported narratively. Anaesthetic respiratory adverse events (RAEs) were reported more consistently. A pooled, weighted risk ratio was estimated using random effects meta-analysis performed in RevMan V.5.3.5,[@R13] using the Mantel-Haenszel implementation of the DerSimonian Laird model, accompanied by tests for heterogeneity (I^2^ statistic). A random effects model was chosen to reflect the range of variation in participants and specialties, and to support the understanding of impacts of ETS exposure on wider surgical populations.

The analysis used available data from all papers which measured ETS exposure as a primary variable of interest, and reported RAE outcomes. Where RAEs were reported in a way that could not be combined, laryngospasm was chosen as the dominant proxy to take into the meta-analysis. Where several time points were reported, the first time point after administration of anaesthetic was selected for inclusion, as it represented the theoretical point of maximum impact of ETS on RAEs.

The impact of missing data was not examined due to limitations in the available datasets and the heterogeneous nature of the studies. Sensitivity was tested by removing individual studies, and then the two most heavily weighted studies, from our analyses.

Results {#s3}
=======

Study selection {#s3a}
---------------

Of the 6875 titles assessed for eligibility, 48 proceeded to full text review, with 28 studies fitting the full eligibility criteria. [Figure 1](#ARCHDISCHILD2016310687F1){ref-type="fig"} summarises the selection process. Twenty-four studies[@R14] used cohorts to examine ETS exposure, and four[@R38] used case--control methodologies.

![Flow chart of the inclusion and exclusion processes for the systematic review. ETS, environmental tobacco smoke.](archdischild-2016-310687f01){#ARCHDISCHILD2016310687F1}

Study characteristics {#s3b}
---------------------

Fifteen studies considered anaesthetic outcomes,[@R14] [@R41] and twelve studies considered surgical outcomes.[@R28] [@R36] [@R38] One further study[@R37] considered behaviour change, a secondary outcome. No studies identified immediate surgical outcomes and, unlike the adult evidence base, no studies considered long-term outcomes of wound or bone healing.

Studies covered ages from birth upwards. One study[@R41] had a protocol that focused on children, but which reported an age range of 0--22 years in its data. The mean age was 5.8, and the reviewers agreed the study should be included as the majority of patients were within the protocol.

The anaesthetic outcome studies used a wide range of surgical groups, including general or mixed surgery,[@R15] [@R18] [@R22] [@R27] [@R41] dental,[@R25] ophthalmology[@R16] and urology[@R17] patients.

All 12 studies considering surgical outcomes focused on ear, nose and throat (ENT) patients. The impact of ETS on this patient group was complicated by the confounding associated with ETS being a cause of delayed surgical recovery and a cause of primary disease or recurrence. In five studies,[@R29] [@R31] [@R38] ETS exposure was treated as a confounding variable, rather than the primary focus of the study.

ETS exposure was usually measured as a binary exposed/unexposed variable, although additional measures such as identifying which family members smoked,[@R17] [@R20] levels of smoking[@R29] and biological markers[@R14] [@R23] were also used. One study showed good correlation between parental questioning and urinary cotinine levels.[@R14]

Studies reported a range of biological and clinical outcomes; the majority of anaesthetic outcomes reported were RAEs, particularly laryngospasm. Oxygen desaturations[@R18] [@R20] [@R22] [@R27] and muscle relaxant dosages[@R21] were used as biological measures. Long-term surgical outcome markers included ciliary regeneration,[@R30] as well as clinical measures such as change in symptoms and signs,[@R34] [@R36] [@R39] complications[@R32] [@R35] [@R40] or repeat procedures.[@R34] [@R38]

Settings {#s3c}
--------

Studies from Australia, Canada, Finland, Ireland, South Korea, Switzerland, Turkey, UK and USA were included.

Risk of bias {#s3d}
------------

Of the 15 studies considering anaesthetic outcomes, 10 were assessed as high quality; for the 12 considering ENT surgical outcomes, 2 were assessed as high quality. The majority of surgical studies considered ETS exposure as a confounding factor in a wider intervention study, and the ETS impact related only to specific subcohorts which had been given less methodological consideration. Online [supplementary file](#SM2){ref-type="supplementary-material"} S2 contains a summary of the assessment.
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[Table 1](#ARCHDISCHILD2016310687TB1){ref-type="table"} summarises the characteristics of the studies examining anaesthetic and recovery outcomes, including methodology, age groups and sample sizes and measurement technique for ETS. It also summarises relevant outcome measures. A similar table describing the surgical papers is available in the online [supplementary file](#SM3){ref-type="supplementary-material"} S3.

###### 

Characteristics of 15 studies focusing on anaesthetic and recovery outcomes

  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Study author                         Year   Outcome methodology          Age group (identified/included)                   Surgical group                                Location      ETS measure (number exposed)                                                      ETS priority   Outcomes                                                                                                               Quality score
  ------------------------------------ ------ ---------------------------- ------------------------------------------------- --------------------------------------------- ------------- --------------------------------------------------------------------------------- -------------- ---------------------------------------------------------------------------------------------------------------------- ---------------
  Drongowski[@R14]                     2003   Prospective cohort           3 months--13 years (n=146/146)                    Inguinal hernia repair                        USA           Parent questionnaire on smoking history/exposure and urinary cotinine (57 ETS+)   1°             Observed respiratory events in induction, emergence and recovery                                                       8

  Jones[@R15]                          2006   Prospective cohort           1--18 years (n=428/405)                           Elective day case: mixed specialties          USA           Parent completed risk factor questionnaire, included smoking history (168 ETS+)   1°             Airway complications observed against graded scale intraoperatively and post anaesthesia                               7

  Kim[@R16]                            2013   Retrospective cohort         Child: not defined (n=159/159)                    Had URI symptom;\                             South Korea   Passive smoking documented in anaesthetic record (28 ETS+)                        1°             Respiratory adverse events documented in notes at intubation, intra-extubation and post-extubation, and in recovery    7
                                                                                                                             ENT and ophthalmology                                                                                                                                                                                                                                                               

  Lakshmipathy[@R17]                   1996   Retrospective cohort         Child: not defined (n=322/310)                    Elective day case: ENT and urology            USA           Parent reported regular smoker at home (96 ETS+)                                  1°             Laryngospasm documented in records                                                                                     7

  Lyons[@R18]                          1996   Prospective cohort           1--12 years (n=?/125)                             Elective day case: not ENT                    Ireland       Parental questionnaire of home and other smoker contacts (63 ETS+)                1°             Respiratory adverse events observed by blinded anaesthetist at preoperative, intraoperative and postoperative points   6

  Mamie[@R19]                          2004   Prospective cohort           1--14 years (n=800/743)                           Mixed specialties                             Switzerland   Parent completed allergy/ asthma questionnaire, including smoking (429 ETS+)      2°             Intraoperative, postoperative and perioperative respiratory adverse events                                             7

  O\'Rourke[@R20]                      2006   Prospective matched cohort   5--15 years (n=93 at recovery; 96 at discharge)   Convenience sample; non-cavity surgery        USA           Direct parental questioning (46 ETS+ at recovery, 49 ETS+ at discharge)           1°             Pulmonary function as percentage predicted; respiratory events secondary outcome                                       7

  Parnis[@R41]                         2011   Prospective case--control    Child: not defined\* (n=?/2051)                   Mixed specialties                             Australia     Parental smoking status as part of wider research questionnaire (926 ETS+)        2°             'Good' vs 'bad' anaesthetic outcome, including adverse respiratory, gastrointestinal and circulatory events            6

  Reisli[@R21]                         2004   Prospective cohort           4--10 years (n=40/40)                             ENT surgery; convenience sample               Turkey        Parental questioning of child\'s overall ETS exposure (20 ETS+)                   1°             Rocuronium dose required for neuromuscular blockade                                                                    6

  Seyidov[@R22]                        2011   Prospective cohort           3 months--12 years (n=402†/385)                   Elective surgery                              Turkey        Parent questioning of quantity of smoke exposure (234 ETS+)                       1°             Respiratory adverse events observed by blinded team                                                                    7

  Skolnick[@R23]                       1998   Prospective cohort           1 month--12 years (n=602/499)                     Elective surgery                              USA           Urinary cotinine and parental enquiry (262 ETS+)                                  1°             Respiratory adverse events                                                                                             8

  Tait[@R24]                           2001   Prospective cohort           1 month--18 years (n=1078/407)                    Elective surgery with active URI              USA           Questionnaire including parental smoking habits                                   2°             Contribution of factor to overall predictive multiple regression model                                                 6

  Thikkurissy[@R25]                    2012   Prospective cohort           19 months--12 years (n=?/99)                      Dental                                        USA           Parental interview on smoking status and quantity (51 ETS+)                       1°             Respiratory adverse events observed by blinded anaesthetist and recovery nurse                                         7

  Tütüncü[@R26]                        2011   Prospective cohort           1--15 years (n=?/150)                             Convenience sample; lower abdominal/urology   Turkey        Parental questionnaire including parent smoking status (100 ETS+)                 1°             Secondary outcome of postoperative respiratory complications                                                           5

  von Ungern-Sternberg *et al*[@R27]   2010   Prospective cohort           Child: not defined (n=10496/9038)                 Anaesthesia for elective and urgent           Australia     Parent smoking report at preoperation check (2929 ETS+)                           1°             Perioperative adverse events                                                                                           8
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

\*Study age range from 0 to 22 years. Mean age 5.8. Reviewers made decision to include in study.

†There is an apparent numerical error in the original paper where the identified total appears not to include exclusions.

ENT, ear, nose and throat; ETS, environmental tobacco smoke; URI, upper respiratory infection.
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Individual study outcomes {#s3e}
-------------------------

### Anaesthetic outcomes {#s3e1}

[Table 2](#ARCHDISCHILD2016310687TB2){ref-type="table"} describes the key findings of studies related to anaesthetic outcomes. Three of fifteen studies[@R18] [@R19] [@R25] considering anaesthetic outcomes did not show that ETS had significant impact on anaesthetic outcomes, with a further study[@R26] showing a higher rate of RAE but not undertaking a statistical analysis. The remaining 11 studies showed significant effects. The most common adverse outcomes were increased rates of laryngospasm, bronchospasm and coughing. Both studies considering biological markers[@R20] [@R21] demonstrated some impact of ETS exposure.

###### 

Key anaesthetic outcomes relevant to the protocol

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
                                                                                                     Observation window                                                                                                                   Event rates\*                             Significance                                                                                                                        
  ------------------------------------------- ------------ ----------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------ ----------------------------------------- --------------------------------------------- ------------------------------------------------------- -------------- -------------- ------------
  Grouped respiratory adverse events (RAEs)   Drongowski   2003                                      ![](archdischild-2016-310687ileq01.jpg)                                                                                                                                                                                                                                              **7/57**       **13/89**      NS

                                                           ![](archdischild-2016-310687ileq01.jpg)                                                                                                                                        25/57                                     33/89                                         NS                                                                                    

                                                                                                     ![](archdischild-2016-310687ileq01.jpg)                                                                                              30/57                                     24/89                                         p\<0.01                                                                               

  Kim                                         2013         ![](archdischild-2016-310687ileq03.jpg)   ***13/28***                                                                                                                          ***32/131***                              OR 2.68 (1.15--6.23)                                                                                                                

  Parnis                                      2001         ![](archdischild-2016-310687ileq03.jpg)   No data                                                                                                                              No data                                   Significant variable in logistic regression                                                                                         

  Seyidov                                     2011         ![](archdischild-2016-310687ileq03.jpg)   **50/234**                                                                                                                           **8/151**                                 p \< 0.005\                                                                                                                         
                                                                                                                                                                                                                                                                                    Dose--response effect observed (p=0.001)                                                                                            

  Skolnick                                    1998                                                   ![](archdischild-2016-310687ileq02.jpg)                                                                                              **8/137**                                 **17/365**                                    p=0.01 for increased RAEs along ETS exposure gradient                                 

  Tait                                        2001         ![](archdischild-2016-310687ileq03.jpg)   No data                                                                                                                              No data                                   RR 1.6 (1.2--2.1)                                                                                                                   

  Thikkurissy                                 2012         ![](archdischild-2016-310687ileq03.jpg)   No data                                                                                                                              No data                                   No significance reported                                                                                                            

  Laryngospasm                                Jones        2006                                                                                                                                                                           ![](archdischild-2016-310687ileq01.jpg)                                                                                                         ***35/168***   ***10/237***   p \< 0.001

  Lakshmipathy                                1996         ![](archdischild-2016-310687ileq03.jpg)   **9/96**                                                                                                                             **2/214**                                 RR 10.0 (2.2--45.6)                                                                                                                 

  Lyons                                       1996         ![](archdischild-2016-310687ileq01.jpg)                                                                                                                                                                                                                                **2/63**                                                **0/62**       NS             

  Mamie                                       2004                                                   ![](archdischild-2016-310687ileq02.jpg)                                                                                              No data                                   No data                                       NS in univariate and multivariate analyses                                            

  O\'Rourke                                   2006         ![](archdischild-2016-310687ileq03.jpg)   **0/54**                                                                                                                             **0/54**                                  None applied                                                                                                                        

  Tütüncü                                     2012                                                   ![](archdischild-2016-310687ileq02.jpg)                                                                                              **6/100**                                 **2/50**                                      None applied                                                                          

  Ungern Sternberg                            2010         ![](archdischild-2016-310687ileq03.jpg)   **99/1075**                                                                                                                          **252/8222**                              RR 3.01 (2.40--3.76)                                                                                                                

  Breath holding                              Jones        2006                                                                                                                                                                           ![](archdischild-2016-310687ileq01.jpg)                                                                                                         *25/168*       *14/237*       p=0.003

  Lyons                                       1996         ![](archdischild-2016-310687ileq01.jpg)                                                                                                                                                                                                                                1/63                                                    3/62           NS             

  Bronchospasm                                Jones        2006                                                                                                                                                                           ![](archdischild-2016-310687ileq01.jpg)                                                                                                         *14/168*       *2/237*        p\<0.001

  Lyons                                       1996         ![](archdischild-2016-310687ileq01.jpg)                                                                                                                                                                                                                                0/63                                                    0/62           NS             

  O\'Rourke                                   2006         ![](archdischild-2016-310687ileq03.jpg)   0/54                                                                                                                                 0/54                                      None applied                                                                                                                        

  Tütüncü                                     2012                                                   ![](archdischild-2016-310687ileq02.jpg)                                                                                              3/100                                     0/50                                          None applied                                                                          

  Ungern Sternberg                            2010         ![](archdischild-2016-310687ileq03.jpg)   49/1075                                                                                                                              144/8222                                  RR 2.60 (1.89--3.58)                                                                                                                

  Hypersecretion                              Jones        2006                                                                                                                                                                           ![](archdischild-2016-310687ileq01.jpg)                                                                                                         *63/168*       *20/237*       p\<0.001

  Tütüncü                                     2012                                                   ![](archdischild-2016-310687ileq02.jpg)                                                                                              18/100                                    4/50                                          None applied                                                                          

  Obstruction                                 Jones        2006                                                                                                                                                                           ![](archdischild-2016-310687ileq01.jpg)                                                                                                         *48/168*       *25/237*       p \< 0.001

  Lyons                                       1996         ![](archdischild-2016-310687ileq01.jpg)                                                                                                                                                                                                                                0/63                                                    0/62           NS             

  Cough                                       Lyons        1996                                      ![](archdischild-2016-310687ileq01.jpg)                                                                                                                                                                                                                                              6/63           2/62           NS

  O\'Rourke                                   2006                                                                                                                                                                                                                                  ![](archdischild-2016-310687ileq01.jpg)       3/54                                                    4/54           None applied   

  Tütüncü                                     2012                                                   ![](archdischild-2016-310687ileq02.jpg)                                                                                              13/100                                    4/50                                          None applied                                                                          

  Desaturation                                Lyons        1996                                      ![](archdischild-2016-310687ileq01.jpg)                                                                                                                                                                                                                                              5/63           2/62           NS

                                                                                                     ![](archdischild-2016-310687ileq01.jpg)                                                                                              19/63                                     7/62                                          NS                                                                                    

  O\'Rourke                                   2006         ![](archdischild-2016-310687ileq03.jpg)   1/54                                                                                                                                 0/54                                      None applied                                                                                                                        

  Tütüncü                                     2012                                                   ![](archdischild-2016-310687ileq02.jpg)                                                                                              13/100                                    6/50                                          None applied                                                                          

  Peak-expiratory flow rate                   O\'Rourke    2006                                      Significantly lower preoperative peak-expiratory flow rate (9.5 points than predicted, p=0.03) in ETS+ children compared with ETS−                                                                                                                                                                                 

  Neuromuscular blockade                      Reisli       2004                                      Time to neuromuscular blockade (measured as T95 and T25 values with rocuronium) was significantly shorter for ETS+ children                                                                                                                                                                                        
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

*\*Italic data* inferred where only percentages available; **bold data** selected for inclusion in systematic review.

CI, confidence interval; ETS, environmental tobacco smoke; NS, non-significant; OR, odds ratio; RR, relative risk.

### Pooled estimate of respiratory adverse event (RAE) risk {#s3e2}

Eleven studies[@R14] [@R20] [@R22] [@R23] [@R25] were eligible for dichotomous meta-analysis with a random effects model to create a pooled estimate of the risk ratio of a RAE with ETS exposure. Data were not available for one study,[@R25] and attempts to contact the author were unsuccessful.

[Figure 2](#ARCHDISCHILD2016310687F2){ref-type="fig"} shows the outcome of the analysis, demonstrating that ETS exposure showed an increased risk ratio for a RAE in the perianaesthetic period of 2.52 (95% CI 1.68 to 3.77, p\<0.0001) compared with not being exposed. There was moderate statistical heterogeneity (I^2^=62%). Subgroup analysis of studies focusing only on laryngospasm was undertaken, recognising the variety of outcomes that grouped RAEs would assess. This retained significance with a risk ratio of 3.54 (95% CI 2.37 to 5.28, p\<0.001) and reduced heterogeneity (I^2^=23%). The subgroup of grouped RAE studies only was marginally non-significant with a risk ratio of 1.75 (95% CI 0.95 to 3.21, p=0.07). The subgroup of only the studies that achieved a high-quality score on the Newcastle--Ottawa scale retained a significant risk ratio of 2.38 (95% CI 1.45 to 3.90, p\<0.0001).

![Meta-analysis of environmental tobacco smoke (ETS) exposure and its association with likelihood of respiratory adverse events (RAEs) in the perianaesthetic period, including subgroups.](archdischild-2016-310687f02){#ARCHDISCHILD2016310687F2}

No evidence of publication bias was identified when examined through a funnel plot ([figure 3](#ARCHDISCHILD2016310687F3){ref-type="fig"}).

![Funnel plot assessing potential for publication bias within anaesthetic outcome studies included in meta-analysis.](archdischild-2016-310687f03){#ARCHDISCHILD2016310687F3}

Sensitivity analysis showed that significance was retained if any individual study was removed, and also if the two most heavily weighted studies were removed.

### Surgical outcomes {#s3e3}

[Table 3](#ARCHDISCHILD2016310687TB3){ref-type="table"} shows that there was inconsistency between studies on the impact of ETS exposure on prognosis after ENT surgical procedures. Three studies[@R32] [@R38] [@R39] showed no significant effects on outcomes, although two studies suggested some evidence that ETS exposure decreased the effectiveness or duration of tympanostomy (ventilation) tubes.[@R28] [@R35] Other studies showed ETS exposure caused a potential deterioration of either subjective[@R29] [@R34] [@R36] or objective[@R30] [@R31] [@R33] [@R40] outcomes.

###### 

Key surgical outcomes relevant to the protocol

  Study                          Key findings
  ------------------------------ -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Atef *et al*[@R30]             Mean recovery of postoperative area was significantly lower in those exposed to ETS compared with those who were not (p\<0.001).
  Chen *et al*[@R29]             Children resident in households with smokers were at higher risk of cough following previous tonsil/adenoidectomy (p\<0.001).
  Gov-Ari *et al*[@R38]          Smoke exposure was not a significant predictor variable for requiring tonsillectomy after previous adenoidectomy.
  Hammarén-Malmi *et al*[@R28]   Once confounding factors were controlled for, only maternal smoking increased risk of recurrent acute otitis media (OR 4.15 95% CI 1.45 to 11.9) after tympanostomy tube insertion.
  Ilicali *et al*[@R39]          No significant difference in early ventilation tube extrusion or persistent otorrhea due to passive smoking demonstrated (maternal smoking OR 0.69 CI 95% 0.29 to 1.67).
  Ilicali *et al*[@R32]          No significant difference in postoperative complication rates due to ETS exposure.
  Kim *et al*[@R40]              Indirect smoking not significantly associated with being in poor outcome group.Multivariate model showed indirect smoking as marginally significant factor (OR 3.377 CI 95% 1.032 to 11.053).
  Maw and Bawden[@R31]           Hazard rate for resolution in ears exposed to parental smoke, 0.61 (CI 95% 0.47 to 0.79). Parental smoking detrimental to clearance of fluid in Cox regression analysis.
  Praveen and Terry[@R35]        Lower median survival of grommet if both parents smoke (59.9 weeks CI 95% 53.9 to 65.9) vs neither parent smokes (86.0 weeks CI 95% 78.7 to 93.3).Increased infection rate for passive smoke exposure (p \<0.001).Increased myringosclerosis for passive smoke exposure (64% vs 20%, p\<0.001).
  Ramadan[@R33]                  Rate of second look abnormal findings in no steroid group, 100% in ETS exposed vs 65% in non-ETS exposed; and 43% in ETS exposed vs 25% in non-ETS exposed for steroid-treated group. No statistics calculated.
  Ramadan[@R34]                  Univariate analysis showed no significant difference in success rate due to smoke exposure. Multivariate analysis reported cigarette smoke exposure as predictor of success (no statistics presented).
  Ramadan and Hinerman[@R36]     Endoscopic sinus surgery less successful in ETS exposed (70% vs 90%, p=0.007).Multivariate analysis showed smoke exposure a significant factor (OR 3.7 95% CI 1.2 to 11.3).

ETS, environmental tobacco smoke.

### Secondary outcomes {#s3e4}

One paper[@R37] considered the impact of surgery on smoking behaviours for relatives of patients, a secondary outcome. Their analysis of survey data showed that parents who smoked were more likely to make a cessation attempt if their child had had recent surgery (OR 2.61 CI 95% 1.56 to 4.35, p\<0.001), but that they were not more likely to maintain abstinence (OR 0.51 CI 95% 0.20 to 1.28, p=0.150).

Discussion {#s4}
==========

Summary of evidence {#s4a}
-------------------

The range of papers, generally assessed as high quality, show that ETS exposure increases the risk of anaesthetic complications for children undergoing surgery. The pooled estimate suggests that children are two and a half times more likely to experience a respiratory adverse event. Subgroup analysis suggests laryngospasm is a particular risk for exposed children.

No evidence was identified considering whether there were delayed harms such as infection or delayed wound and bone healing. The only evidence of the impact on surgical outcomes relates to ENT surgery, with a mixed picture of impact on surgical success. The quality of studies is mixed, and complex interactions make establishing causal linkages difficult.

Only one observational study[@R37] looked at the impact of surgery on parental behaviour. It showed parents were more likely to make a quit attempt if their child had surgery in the preceding year, but that this attempt was no more likely to be successful.

The review is important to clinical teams in anticipating the increased risks of complications and discussing anaesthesia risks for ETS-exposed children. This information may create a 'teachable moment' for parents and carers to consider smoking cessation, giving our findings public health implications as well.

Strengths and limitations {#s4b}
-------------------------

This review is the first to bring together evidence of the impact of ETS exposure on outcomes of paediatric surgery. The search strategy was comprehensive and applied across the appropriate range of sources. It is disappointing that it did not identify papers covering outcomes such as infection and wound healing, but this is judged to be due to an absence of evidence.

Papers relating to anaesthetic outcomes were of good quality, reflecting the short-term outcomes being observed, and opportunities to blind observers to exposure status. A variety of methods were used for assessing ETS levels, but biological markers offered more robust techniques for stratifying cohorts. Where less reliable methods were used alongside biological markers, it was reassuring to note reasonable segregation of the cohorts.

The surgical outcomes evidence is limited. ETS exposure was often considered as a coincidental variable or subgroup. This was accommodated by evaluating paper quality solely on the interaction within the ETS study element, but it meant papers scored poorly on quality assessment because they had never been conceived to address our research question.

Also, ETS exposure increases the incidence and prevalence of ENT conditions, and we were clear that an appropriate temporal relationship was required; the detail available in some studies meant a reverse relationship could not be excluded. This is illustrated by Chen\'s[@R29] conclusion that tonsillectomy increased the influence of ETS on cough, as opposed to ETS increasing the persistence of cough after tonsillectomy. Both are feasible interpretations which cannot be separated by this review. Well-conceived methodologies[@R28] [@R32] that can demonstrate temporality do exist that can address this.

Conclusions {#s4c}
-----------

Exposure to ETS increases the risk of respiratory adverse events during anaesthesia for children undergoing surgery. It may also impact on the success of surgical procedures, particularly in ENT surgery. Exploration is now needed of whether information on increased risk provides an opportunity to promote smoking cessation, and whether even temporary cessation can be effective in reducing risk.
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